GlassScriptPhysician profile
Jude O Ediae
NPI 1619137569
$13,029.30
in general payments reported to CMS, 2019-2025
33 companies · $1,437 in 2025
The $1,437 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,073 · 2020: $883 · 2021: $1,482 · 2022: $1,760 · 2023: $1,287 · 2024: $2,107 · 2025: $1,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,812 · Education: $19.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,811.94 |
| Education | $19.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,007.81 | 2019-2020 | |
| Medtronic, INC. | $2,458.41 | 2021-2025 | Micra, Linq II, Corevalve Evolut R |
| Boston Scientific Corporation | $1,260.62 | 2019-2025 | Watchman Flx, Synergy, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $698.55 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $615.77 | 2019-2025 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $608.58 | 2020-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $578.60 | 2019-2024 | Camzyos, Eliquis |
| Cardiovascular Systems INC. | $574.39 | 2019-2021 | |
| Amgen INC. | $455.27 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $403.19 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.47 | 2019-2025 | Jardiance |
| Abiomed | $305.01 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $294.41 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $214.65 | 2019-2023 | Xarelto |
| Corindus INC. | $148.78 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $123.17 | 2021-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $113.76 | 2025 | |
| Abbott Laboratories | $113.33 | 2024-2025 | Amplatzer Amulet, Jot Dx, Aveir |
| Shockwave Medical, INC | $96.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $91.30 | 2019 | |
| Bardy Diagnostics, INC. | $87.82 | 2020 | |
| Amarin Pharma, INC. | $85.01 | 2019-2022 | |
| Stryker Corporation | $78.30 | 2025 | Flowtriever |
| Baxter Healthcare | $66.14 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $61.29 | 2024 | |
| Lundbeck LLC | $35.82 | 2019-2021 | |
| Daiichi Sankyo INC. | $30.79 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.60 | 2025 | Vpriv |
| Philips North America LLC | $25.39 | 2022 | |
| Bridgebio Pharma, INC. | $15.90 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $14.50 | 2020 | |
| Preventice Services, LLC | $13.72 | 2019 | |
| Teleflex LLC | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jude Ediae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.